148 The influence of moulds as an independent risk factor for decreasing lung function in cystic fibrosis  by Guy, C.E. et al.
5. Microbiology S37
145 Cystic ﬁbrosis airways, a particular ecological niche for bacterial
species as-yet non-reported in man
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Airways of CF patients represent a particular ecological niche recognized as a
remarkable model system for studies on bacterial adaptation. Recent sequence-
based and cultivation-based studies of CF airway microbiota revealed the presence
of multiple species not previously reported in man.
First report of 8 bacterial taxa not previously isolated in man is described herein in
sputum samples of 8 CF patients. All were aerobic, gram-negative bacilli. Most of
them were oxidase-positive and showed enhanced growth at 30ºC. 16S rRNA gene
sequencing identiﬁed Sphingomonas pseudosanguinis, Aquamicrobium lusatiense,
Phyllobacterium myrsinacearum, Shinella sp., Acetobacter fabarum, Advenella
kashmirensis, Chryseobacterium bovis and Pseudomonas brenneri. These bacteria
have been described either in cow’s milk or in various environments: water, plants
and soil. A. fabarum increased the list of acetic acid bacteria − recently recognized
as emerging opportunistic human pathogens − recovered from human samples.
Their impact on the airway microbiota and on the clinical evolution has still
to be determined. Some species might speciﬁcally colonize the CF respiratory
tract in relation to particular metabolic traits, like growth in acidic conditions for
Acetobacter and Advenella. The role of this colonization on the global resistance
of the microbiota to antimicrobial agents should be evaluated since most of
environmental opportunistic pathogens found in human are known to display high
level of resistance.
146 Chronic Aspergillus fumigatus colonisation of the
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Objectives: (1) To study the rate of Aspergillus fumigatus (Af ) airway colonisation
in a tertiary paediatric CF cohort. (2) To evaluate the sensitivity of routine clinical
sampling at detecting Af . (3) To compare lung function of Af -colonised and non-
colonised children.
Methods: 8-year retrospective cohort analysis (Sep 2002–Aug 2010). Patient
clinical and microbiological data were extracted from our local database and case
notes.
Results: 2703 respiratory specimens from 51 children were available. 19 (37%)
had a positive Af culture at least once during the 8-year period, with 10 (20%)
children persistently colonised (deﬁned as at least two positive Af cultures in any
one-year period: Amin et al., 2010). The median age at ﬁrst Af -positive culture
was 9.0 years (range 3.1–15.6). In 15 of the 19 children (79%), Pseudomonas was
isolated at least once. Of 48 broncho-alveolar lavage (BAL) specimens, 29% tested
positive for Af , compared with 14% of 976 sputum samples and 0.8% of 1679
cough swabs. Within a 3-month period of any Af -positive BAL sample, Af was
cultured from only 19.5% of 41 sputum samples and 2.7% of 37 cough swabs.
Of 7 children in our cohort classed as having ‘severe’ lung disease (Schlucter et
al., 2006), 4 were chronically colonised with Af , only one of whom met diagnostic
criteria for ABPA.
Conclusion: Chronic Af colonisation of the CF airway is common, and may be
associated with worse lung function. In our practice, BAL appears superior at
detecting lower airway Af compared to sputum samples and cough swabs.
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Diagnosis of ABPA is often difﬁcult in CF patients as the clinical symptoms
associated mimic those of exacerbations. The Cystic Fibrosis Foundation proposed
the following diagnostic criteria for ABPA: Respiratory deterioration not attributable
to another cause, serum IgE higher than 500 IU/ml, positive skin test to A. fumigatus
or serum speciﬁc IgE, and one or both of the following: speciﬁc serum precipitins or
IgG, and new or recent chest imaging abnormalities. Recently, TARC (Thymus and
Activation Regulated Chemokine) has been proposed for diagnosis in this patient
group. This study aims to examine TARC and determine the correlation between
pre-existing makers, to evaluate the utility of this as an improved diagnostic assay.
Forty serum samples submitted by CF clinicians between March and July 2010
were examined. Patients had a clinical suspicion of ABPA; however, there were no
guidelines to initiate sampling. All standard markers IgG, speciﬁc and total IgE
were tested in the routine diagnostic lab, and the TARC assay was performed using
a commercially available ELISA. Patients had an average age of 9 years (range
2−14) and 48% were female. Statistical analysis of the data showed no correlation
between standard and the new TARC assay: TARC vs IgG (p = 0.491), TARC vs
speciﬁc IgE (p = 0.869), TARC vs total IgE (p = 0.264). Implementing a lab based
TARC assay without detailed clinical protocols including sampling at known time
points during an established illness does not add to the serological diagnosis of
ABPA. This does not preclude a potential utility for this assay however further
analysis of TARC correlated with clinical diagnostic criteria is required.
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The role of moulds in CF patients is complicated and positive cultures can often be
disregarded as contaminants when there is a lack of signiﬁcant clinical deterioration.
In this study we examined patient lung function relative to pathogens isolated from
their respiratory specimens. Patients were categorised into 4 groups depending on
the organisms isolated from sputum over an 16 month period the groups included
patients where no pathogens were isolated (Negative); where a pseudomonad (Pa)
had been isolated; where a mould had been isolated and where both a Pa and mould
have been isolated. Statistical analysis was performed using a two-tailed t-test. There
were no signiﬁcant differances in any of the demographic data in each group this
included (age, sex, BMI, DEPCAT score). These result show that there was a
signiﬁcant difference between the negative patients and those where Pa had been
isolated (p = 0.0042) however there was no signiﬁcant difference between negative
patients and patient where mould was isolated (p = 0.1955) When analysing the
patients were moulds were isolated in conjunction with Pa there was a trend toward
more pronounced lung decline (p = 0.0022) suggesting that there is a cumulative
effect where a greater decline in lung function (% predicted FEV) was noted in
the patients with both pathogens. In conclusion greater emphasis has to be placed
on moulds isolated from specimens in CF patients to prevent accelerated lung
function decline in this patient group. This study audited samples over sixteen
months and it would be beneﬁcial to extend this to determine if this trend becomes
more pronounced the longer patients are co-colonised with both moulds and Pa.
